BRANDL TALOS advised Resonate Bio on spin-off from the University of Vienna

Press release • Venture Capital & Start Ups from Stephan Strass

BRANDL TALOS advised biotech company Resonate Bio on the spin-off from the University of Vienna.

Resonate Bio is a Vienna-based biotech company pioneering the use of artificial intelligence and nuclear magnetic resonance (AI-NMR) to bring “movies” to structure-based drug design and in doing so drug “undruggable” dynamic proteins across therapeutic areas. The AI-NMR drug discovery platform was developed through years of research within the Christian Doppler Laboratory between the University of Vienna and Boehringer Ingelheim.

» Thanks a lot Stephan and Daniel and the team at Brandl Talos, you have been invaluable to us at Resonate Bio. We‘ve hit the ground running thanks to your awesome agility and expert advise. «

The BRANDL TALOS team advising Resonate Bio on the spin-off consisted of Stephan Strass and Daniel Habich.

The team

Stephan Strass

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 16
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 4
            [name] => Partner
            [slug] => partner
            [term_group] => 0
            [term_taxonomy_id] => 4
            [taxonomy] => category
            [description] => Partner
            [parent] => 0
            [count] => 11
            [filter] => raw
        )

)

Partner / Venture Capital & Start Ups, Corporate Law & Transactions, BioTech & Lifescience

Stephan advises innovative start-ups, institutional and strategic investors and other companies on acquisitions, financing rounds, joint ventures and exit transactions with a focus on highly regulated industries such as life sciences, biotech and leisure & entertainment. He further specializes in commercial transactions in the life science and biotech sector, including university spin-offs, strategic collaborations, patent and technology license agreements and IP purchase transactions.

He has co-authored commentaries on the EU Merger Act and the Investment Fund Act, and is the author of many academic publications.

University of Vienna, Faculty of Law (Mag. iur. 2015)
Harvard Law School, Master of Laws (LL.M. 2019)

Latest insights into
Venture Capital & Start Ups

BRANDL TALOS advises VitreaLab on USD 11m Series A financing round

Press release • Venture Capital & Start Ups from Adrian Zuschmann, Markus Reinfeld

BRANDL TALOS has advised Vitrealab in connection with a USD 11m Series A financing round.

BRANDL TALOS advises Smedvig Ventures on Series A financing of chatlyn

Press release • Venture Capital & Start Ups from Roman Rericha, Adrian Zuschmann

BRANDL TALOS has advised lead investor Smedvig Ventures on the EUR 8 million Series A financing round of AI start-up chatlyn.

BT advises investor consortium on record-breaking seed financing of Emmi AI

Press release • Venture Capital & Start Ups from Roman Rericha, Adrian Zuschmann

BT advised investors 3VC, Speedinvest, Serena and PUSH on the seed financing round of Emmi AI. With a total investment of EUR 15 million, the round marks the largest seed funding ever raised by a startup in Austria.